Quick Dispatch:
Your surmount-1 tirzepatide obesity nejm 2022 weight loss percent Tirzepatide as Compared with Semaglutide for the Treatment of Obesity orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your surmount-1 tirzepatide obesity nejm 2022 weight loss percent Tirzepatide as Compared with Semaglutide for the Treatment of Obesity ships.
Need Help?
Questions about surmount-1 tirzepatide obesity nejm 2022 weight loss percent Tirzepatide as Compared with Semaglutide for the Treatment of Obesity, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for surmount-1 tirzepatide obesity nejm 2022 weight loss percent Tirzepatide as Compared with Semaglutide for the Treatment of Obesity in your area.
SURMOUNT-5 Trial
28.60
Tirzepatide for Obesity: Highlights from the SURMOUNT-1 Trial
21.64
First head-to-head trial compares tirzepatide and semaglutide - Results are in!
27.57
STEP 1 (NEJM 2021) showed that semaglutide 2.4 mg once weekly produced a mean weight loss of 14.9% in 1,961 adults with obesity — with 1 in 3 participants losing over 20%
21.46
What to Expect on Tirzepatide: Month-by-Month Weight Loss Timeline
23.51
Tirzepatide lowers body weight for adults with obesity, regardless of disease duration
26.88
In the SURMOUNT-4 trial, 82.5% of adults with obesity regained ≥25% of initial weight lost within one year of tirzepatide withdrawal; most showed reversal of cardiometabolic improvements. https://ja.ma/4qaMLfO
28.79
